SCHEMBL18800466

SCHEMBL18800466

COc1cccc(-c2cnc(Nc3ccc(C)cc3C)c(N)c2C(=N)N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ BTK Q06187 4/20 0.41
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ MAPK1 P28482 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TDO2 P48775 1/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ SRC P12931 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800468 0.90 BTK (0.49) DHODHADORA2AADORA1BTKCYP1A2
SCHEMBL18800786 0.88 RAPGEF4 (0.44) DHODHADORA2AADORA1BTKCYP1A2
SCHEMBL18800760 0.83 BTK (0.61) DHODHADORA2AADORA1BTKCYP1A2
SCHEMBL18800563 0.83 BTK (0.58) ADORA2AADORA1BTKCYP1A2CYP3A4
SCHEMBL18800792 0.81 BTK (0.47) DHODHADORA2AADORA1BTKLMNA
SCHEMBL18800891 0.80 BTK (0.62) DHODHADORA2AADORA1BTKALDH1A1
SCHEMBL18800784 0.79 BTK (0.46) DHODHADORA2AADORA1BTK
SCHEMBL18800559 0.79 BTK (0.58) BTKALDH1A1MEN1TSHRKMT2A
SCHEMBL18800772 0.77 ADORA1 (0.43) ADORA1BTKALDH1A1LMNAMEN1
SCHEMBL8402322 0.76 BTK (0.71) DHODHADORA2AADORA1BTKCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback